Skip to main content
    T

    Tenax Therapeutics Inc (TENX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.48
    -0.14 (-8.64%)

    Market Cap: $73.77M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Tenax Therapeutics Inc (TENX) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Tenax Therapeutics (TENX) trades at 0.7x book value. Its P/B of 0.7x is below its 5-year median of 1.0x. Its forward P/E is 0.3x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E0.3x
    Price to book0.7x
    EV/FCF0.7x
    PEGN/A
    FCF yield-62.4%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/B0.7x1.0xN/A
    Medians of month-end values through Oct 2026: 60 months (5-year).

    Valuation History

    Over the 5 of the 10 year ends shown that have a P/B, its P/B ranged from 0.7x in 2023 to 6.2x in 2021.

    Year endPriceP/SP/B
    2025$12.19N/A4.9x
    2024$6.19N/A1.0x
    2023$21.97942.6x0.7x
    2022$178.24N/A2.0x
    2021$1,664.00N/A6.2x
    2020$2,976.00N/AN/A
    2019$2,256.00N/AN/A
    2018$1,936.00N/AN/A
    2017$15,680.00N/AN/A
    2016$62,400.00N/AN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About TENX

    What is TENX's forward P/E ratio?

    Tenax Therapeutics has a forward P/E ratio of 0.3x.